File Download
  Patent History
  • Application
    US 12/3812265 2011-07-29
  • Granted
    US 20130324605 2013-12-05

granted patent: USES OF CIMIRACEMATE A AND RELATED COMPOUNDS FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES

TitleUSES OF CIMIRACEMATE A AND RELATED COMPOUNDS FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES
Granted PatentUS 20130324605
Granted Date2013-12-05
Priority Date2011-07-29 US 12/3812265
2010-07-30 US 12/369428P
2011-07-29 PCT/IB2011002582
Inventors
Issue Date2013
Citation
US Patent US 20130324605. Washington, DC: US Patent and Trademark Office (USPTO), 2013 How to Cite?
AbstractThe present invention pertains to Cimiracemate A and related compounds that are useful as inhibitors of 5-lipoxygenase (5-1. OX) activity and various proinflammatory mediators such as lipoxins, leukotrienes (e.g., LTA4, LTB4, LTC4, LTD4, and LTE4), prostaglandins, and thromboxanes. The present invention also provides therapeutic methods and compositions for treatment of inflammation and inflammatory conditions, including allergenic reactions, diseases associated with cell proliferation, neoangiogenesis, and cardiovascular diseases.
Persistent Identifierhttp://hdl.handle.net/10722/206718

 

DC FieldValueLanguage
dc.date.accessioned2014-11-28T03:45:29Z-
dc.date.available2014-11-28T03:45:29Z-
dc.date.issued2013en_US
dc.identifier.citationUS Patent US 20130324605. Washington, DC: US Patent and Trademark Office (USPTO), 2013en_US
dc.identifier.urihttp://hdl.handle.net/10722/206718-
dc.description.abstractThe present invention pertains to Cimiracemate A and related compounds that are useful as inhibitors of 5-lipoxygenase (5-1. OX) activity and various proinflammatory mediators such as lipoxins, leukotrienes (e.g., LTA4, LTB4, LTC4, LTD4, and LTE4), prostaglandins, and thromboxanes. The present invention also provides therapeutic methods and compositions for treatment of inflammation and inflammatory conditions, including allergenic reactions, diseases associated with cell proliferation, neoangiogenesis, and cardiovascular diseases.en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documentsen_US
dc.titleUSES OF CIMIRACEMATE A AND RELATED COMPOUNDS FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSESen_US
dc.typePatenten_US
dc.identifier.authorityLAU, ALLAN SIK YIN=rp00474en_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.hkuros179580en_US
dc.contributor.inventorLAU, ALLAN SIK YINen_US
dc.contributor.inventorYANG, CINDY LAI HUNGen_US
patents.identifier.applicationUS 12/3812265en_US
patents.identifier.grantedUS 20130324605en_US
patents.description.assigneeLAU ALLAN SIK YIN [CN]; YANG CINDY LAI HUNG [CN]; VERSITECH LTD [CN]; PURAPHARM COMPANY LTD [CN]en_US
patents.description.countryUnited States of Americaen_US
patents.date.granted2013-12-05en_US
patents.date.application2011-07-29en_US
patents.date.priority2011-07-29 US 12/3812265en_US
patents.date.priority2010-07-30 US 12/369428Pen_US
patents.date.priority2011-07-29 PCT/IB2011002582en_US
patents.description.ccusen_US
patents.relation.familyCN 103298465 (A) 2013-09-11en_US
patents.relation.familyWO 2012014085 (A2) 2012-02-02en_US
patents.description.kindA1en_US
patents.typePatent_granteden_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats